title: Complete remission upon bortezomib-dexamethasone therapy in three heavily pretreated multiple myeloma patients relapsing after allogeneic stem cell transplantation.
authors.forename: Patrizia
authors.initials: P
authors.lastname: Tosi
authors.forename: Elena
authors.initials: E
authors.lastname: Zamagni
authors.forename: Delia
authors.initials: D
authors.lastname: Cangini
authors.forename: Paola
authors.initials: P
authors.lastname: Tacchetti
authors.forename: Giulia
authors.initials: G
authors.lastname: Perrone
authors.forename: Michela
authors.initials: M
authors.lastname: Ceccolini
authors.forename: Michele
authors.initials: M
authors.lastname: Baccarani
authors.forename: Michele
authors.initials: M
authors.lastname: Cavo
mesh_terms: D000328:Adult; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage*; D000069286:Bortezomib; D003907:Dexamethasone / Q000008:administration & dosage*; D005260:Female; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000517:prevention & control*; D011480:Protease Inhibitors / Q000008:administration & dosage*; D011719:Pyrazines / Q000008:administration & dosage*; D012008:Recurrence; D012074:Remission Induction; D016879:Salvage Therapy; D033581:Stem Cell Transplantation; D013997:Time Factors; D014184:Transplantation, Homologous
chemical_list: D000893:Anti-Inflammatory Agents; D001897:Boronic Acids; D011480:Protease Inhibitors; D011719:Pyrazines; D000069286:Bortezomib; D003907:Dexamethasone